Market Recap — October 8, 2026
Recap of insider activity, SEC filings, and market-moving news for October 8, 2026.
Last generated Oct 21, 2026, 5:01 PM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Nasdaq Denies Appeal — Nvni Group Delisted, Trading Suspends October 9
DAAQ Signs $250M Merger with Titan Strategics to Create Renaissance Nuclear
DAAQ Signs $250M Merger with Titan Strategics to Create Renaissance Nuclear
Blue Gold Flags Going Concern Doubt, Reprices Related-Party Debt to $0.50
Hess Midstream to Acquire Chevron's DJ Basin Assets for $200M, Cut Share Count ~40%
Jaguar Health Seeks Approval for Up to 92.9% Dilution, Reverse Split, and ELOC Floor Price Cut
Boundless Bio Files S-4 for Reverse Merger with Serapha Bio: 96.2% Dilution, $44-48M Dividend, and Beam Litigation Risk
APPlife 10-K: Going Concern, $4.7M Loss, Multiple Debt Defaults, and Material Weaknesses
Starbucks Explores Takeover of Chipotle in Potential $41B Restaurant Mega-Deal
SEGG to Restate 2023-2025 Financials After Overstating Revenue
SEGG Quantifies Fraud Restatement, Flags Going Concern Doubt
SEGG Discloses Fraudulent 2020-21 Transactions, Restates Multiple Years of Financials
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
DAAQ Signs $250M Merger with Titan Strategics to Create Renaissance Nuclear
Hess Midstream to Acquire Chevron's DJ Basin Assets for $200M, Cut Share Count ~40%
Starbucks Explores Takeover of Chipotle in Potential $41B Restaurant Mega-Deal
SEGG to Restate 2023-2025 Financials After Overstating Revenue
SEGG Discloses Fraudulent 2020-21 Transactions, Restates Multiple Years of Financials
Viatris to Acquire Pacira BioSciences for $36.50/Share in $1.65B All-Cash Deal
Viatris to Acquire Pacira BioSciences for $1.65B in Cash, Adding Non-Opioid Pain Franchise
Viatris to Acquire Pacira BioSciences in Non-Opioid Pain Push
Crescent Energy Launches $1B Stock Offering to Fund $4.2B Eagle Ford Deal
Crescent Energy to Acquire Devon's Eagle Ford Assets for $4.22B Cash
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.